Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates

Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of$ 0.34. This compares to loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.88%. A quarter ago, it was expected that this company would post a loss of$ 0.34 per share when it actually produced a loss of $1.27, delivering a surprise of -273.53%.Over the last four quarters, the company has surp ...